Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA

BACKGROUND: Gait instability is one of the disabling clinical features of majority of patients suffering from Parkinson’s disease (PD). It is partially responsive to dopamine replacement therapy. Precise evaluation of distinct l-DOPA-sensitive and l-DOPA-resistant gait profiles might help in plannin...

Full description

Bibliographic Details
Main Authors: Banashree Mondal, Supriyo Choudhury, Rebecca Banerjee, Koustav Chatterjee, Sayam Ghosal, Sidharth S Anand, Hrishikesh Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Annals of Movement Disorders
Subjects:
Online Access:http://www.aomd.in/article.asp?issn=2590-3446;year=2019;volume=2;issue=1;spage=21;epage=27;aulast=Mondal
_version_ 1819115988992393216
author Banashree Mondal
Supriyo Choudhury
Rebecca Banerjee
Koustav Chatterjee
Sayam Ghosal
Sidharth S Anand
Hrishikesh Kumar
author_facet Banashree Mondal
Supriyo Choudhury
Rebecca Banerjee
Koustav Chatterjee
Sayam Ghosal
Sidharth S Anand
Hrishikesh Kumar
author_sort Banashree Mondal
collection DOAJ
description BACKGROUND: Gait instability is one of the disabling clinical features of majority of patients suffering from Parkinson’s disease (PD). It is partially responsive to dopamine replacement therapy. Precise evaluation of distinct l-DOPA-sensitive and l-DOPA-resistant gait profiles might help in planning therapy of PD patients with gait disorder.METHOD: In this cross-sectional analytical study, we measured the gait parameters of 70 patients and 37 healthy participants using a 6.1-m long electronic walkway containing thousands of pressure sensors embedded in a carpet. The patients were evaluated in their OFF and ON phases of l-DOPA medication, and the data were compared with age- and gender-matched healthy controls.RESULTS: Except for the cadence, most gait parameters including velocity, stride length, and step length were deranged in PD patients. The mean velocity was significantly higher among healthy volunteers (99.19cm/s) compared to PD patients (73.90cm/s, P value 0.0001). However, the mean cadence was comparable between healthy and patient groups (103.29 vs. 103.39, P value 0.966). Certain temporal parameters (cadence, cycle time, and swing time) were nonresponsive to the dopaminergic therapy.CONCLUSION: On the basis of the findings, we propose that l-DOPA treatment improves most of the spatiotemporal gait parameters but cannot completely eliminate the risk of fall.
first_indexed 2024-12-22T05:09:57Z
format Article
id doaj.art-d557d86420774cb1845e7a6449608771
institution Directory Open Access Journal
issn 2590-3446
2590-3454
language English
last_indexed 2024-12-22T05:09:57Z
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Annals of Movement Disorders
spelling doaj.art-d557d86420774cb1845e7a64496087712022-12-21T18:38:00ZengWolters Kluwer Medknow PublicationsAnnals of Movement Disorders2590-34462590-34542019-01-0121212710.4103/AOMD.AOMD_19_18Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPABanashree MondalSupriyo ChoudhuryRebecca BanerjeeKoustav ChatterjeeSayam GhosalSidharth S AnandHrishikesh KumarBACKGROUND: Gait instability is one of the disabling clinical features of majority of patients suffering from Parkinson’s disease (PD). It is partially responsive to dopamine replacement therapy. Precise evaluation of distinct l-DOPA-sensitive and l-DOPA-resistant gait profiles might help in planning therapy of PD patients with gait disorder.METHOD: In this cross-sectional analytical study, we measured the gait parameters of 70 patients and 37 healthy participants using a 6.1-m long electronic walkway containing thousands of pressure sensors embedded in a carpet. The patients were evaluated in their OFF and ON phases of l-DOPA medication, and the data were compared with age- and gender-matched healthy controls.RESULTS: Except for the cadence, most gait parameters including velocity, stride length, and step length were deranged in PD patients. The mean velocity was significantly higher among healthy volunteers (99.19cm/s) compared to PD patients (73.90cm/s, P value 0.0001). However, the mean cadence was comparable between healthy and patient groups (103.29 vs. 103.39, P value 0.966). Certain temporal parameters (cadence, cycle time, and swing time) were nonresponsive to the dopaminergic therapy.CONCLUSION: On the basis of the findings, we propose that l-DOPA treatment improves most of the spatiotemporal gait parameters but cannot completely eliminate the risk of fall.http://www.aomd.in/article.asp?issn=2590-3446;year=2019;volume=2;issue=1;spage=21;epage=27;aulast=Mondaldopa responsivenessgaitgaitrite®parkinson’s disease
spellingShingle Banashree Mondal
Supriyo Choudhury
Rebecca Banerjee
Koustav Chatterjee
Sayam Ghosal
Sidharth S Anand
Hrishikesh Kumar
Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
Annals of Movement Disorders
dopa responsiveness
gait
gaitrite®
parkinson’s disease
title Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
title_full Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
title_fullStr Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
title_full_unstemmed Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
title_short Analysis of gait in Parkinson’s disease reflecting the effect of l-DOPA
title_sort analysis of gait in parkinson s disease reflecting the effect of l dopa
topic dopa responsiveness
gait
gaitrite®
parkinson’s disease
url http://www.aomd.in/article.asp?issn=2590-3446;year=2019;volume=2;issue=1;spage=21;epage=27;aulast=Mondal
work_keys_str_mv AT banashreemondal analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa
AT supriyochoudhury analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa
AT rebeccabanerjee analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa
AT koustavchatterjee analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa
AT sayamghosal analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa
AT sidharthsanand analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa
AT hrishikeshkumar analysisofgaitinparkinsonsdiseasereflectingtheeffectofldopa